These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33092235)

  • 1. Genetic Heterogeneity of Single Circulating Tumour Cells in Colorectal Carcinoma.
    Hamid FB; Gopalan V; Matos M; Lu CT; Lam AK
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma.
    Hamid FB; Lu CT; Matos M; Cheng T; Gopalan V; Lam AK
    Cancer Genet; 2021 Jun; 254-255():48-57. PubMed ID: 33610860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
    Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
    Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
    Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma.
    Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell Phenotypic Profiling of CTCs in Whole Blood Using an Integrated Microfluidic Device.
    Pei H; Li L; Wang Y; Sheng R; Wang Y; Xie S; Shui L; Si H; Tang B
    Anal Chem; 2019 Sep; 91(17):11078-11084. PubMed ID: 31373191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
    Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L
    Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
    Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
    Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer.
    Kondo Y; Hayashi K; Kawakami K; Miwa Y; Hayashi H; Yamamoto M
    BMC Cancer; 2017 May; 17(1):311. PubMed ID: 28468669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.
    Powell AA; Talasaz AH; Zhang H; Coram MA; Reddy A; Deng G; Telli ML; Advani RH; Carlson RW; Mollick JA; Sheth S; Kurian AW; Ford JM; Stockdale FE; Quake SR; Pease RF; Mindrinos MN; Bhanot G; Dairkee SH; Davis RW; Jeffrey SS
    PLoS One; 2012; 7(5):e33788. PubMed ID: 22586443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation.
    Huang Q; Li S; Hu X; Sun M; Wu Q; Dai H; Tan Y; Sun F; Wang C; Rong X; Liao W; Peng J; Xiao J; Huang L; Wang J; Liang B; Lin K; Liu Y; Shi M
    J Exp Clin Cancer Res; 2020 Jan; 39(1):25. PubMed ID: 32000836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
    Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
    PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.
    Insua YV; Cámara J; Vázquez EB; Fernández A; Rivera FV; Silva MJVV; Barbazán J; Muinelo-Romay L; Folgar SC; Abalo A; López-López R; Abal M; Alonso-Alconada L
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.